Response Assessment in Neuro-Oncology Criteria

Known as: Response Assessment in Neuro-Oncology (RANO) Response Criteria, RANO Response Criteria, RANO 
An update to the MacDonald criteria for assessing disease progression and treatment response in glioblastoma multiforme (GBM).
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Development of novel therapies for CNS tumors requires reliable assessment of response and progression. This requirement has been… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2015
Review
2015
CNS metastases are the most common cause of malignant brain tumours in adults. Historically, patients with brain metastases have… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Review
2014
Review
2014
Background The Macdonald criteria and the Response Assessment in Neuro-Oncology (RANO) criteria define radiologic parameters to… (More)
  • figure 1
Is this relevant?
Review
2013
Review
2013
Since 1990, the primary criteria used for assessing response to therapy in high-grade gliomas were those developed by Macdonald… (More)
  • table 1
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
2013
2013
Criteria for new drug approval include demonstration of efficacy. In neuro-oncology, this is determined radiographically… (More)
  • figure 1
  • table I
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2012
Highly Cited
2012
To investigate prospectively the potential of O-(2-[18F]fluoroethyl)-l-tyrosine (18F-FET) PET in comparison to MRI for the… (More)
  • figure 1
  • figure 2
  • table 3
  • figure 4
Is this relevant?
Review
2011
Review
2011
Bevacizumab is thought to normalize tumor vasculature and restore the blood-brain barrier, decreasing enhancement and peritumoral… (More)
  • table 1
  • table 2
  • figure 1
Is this relevant?
Highly Cited
2007
Highly Cited
2007
PURPOSE Response Evaluation Criteria in Solid Tumors (RECIST) are insensitive in evaluating imatinib-treated gastrointestinal… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE The relationships between mismatch repair (MMR) protein expression, microsatellite instability (MSI), family history, and… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
BACKGROUND AND AIMS There are multiple criteria for the clinical diagnosis of hereditary non-polyposis colorectal cancer (HNPCC… (More)
Is this relevant?